Form 13-F position report

ATYR PHARMA INC

Reported by ACADIAN ASSET MANAGEMENT LLC

LIFE CUSIP 002120103 Manager CIK 0000916542

Reported 0 shares, down 121,851 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2019
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 13 Through Q2 2019

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for ATYR PHARMA INC held by ACADIAN ASSET MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

25 managers reported ATYR PHARMA INC for Q2 2019.

Managers reporting ATYR PHARMA INC in Q2 2019.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FEDERATED HERMES INC New 7,393,715 +7,393,715 < 0.01% $2,709,000 1 qtr
FMR LLC Added 6,880,252 +2,551,802 < 0.01% $2,521,000 17 qtrs
VIKING GLOBAL INVESTORS LP Unchanged 3,209,955 0 < 0.01% $1,176,000 8 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 1,845,873 +305,314 < 0.01% $676,000 12 qtrs
VANGUARD GROUP INC Added 1,779,024 +33,702 < 0.01% $652,000 17 qtrs
BlackRock Inc Reduced 125,916 -57,309 < 0.01% $46,000 13 qtrs
WEDBUSH SECURITIES INC Added 67,270 +41,271 < 0.01% $25,000 2 qtrs
TWO SIGMA INVESTMENTS LP Reduced 39,084 -28,220 < 0.01% $14,000 5 qtrs
UBS Group AG Added 27,029 +27,028 < 0.01% $10,000 17 qtrs
NORTHERN TRUST CORPORATION Reduced 28,236 -1,900 < 0.01% $10,000 16 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2019
Filed
August 08, 2019
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.